• ESMO presentations highlight advances in kidney cancer, melanoma, lung cancer

    2 monthes ago - By Healio

    This year's European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma.
    Healio presents the following updates from ESMO that may be relevant to your practice.
    1. The addition of cabozantinib to nivolumab and ipilimumab conferred a significant PFS benefit among patients with advanced renal cell carcinoma.
    Read more ...